Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells

Molecular Nutrition and Food Research

Volumn 56, Issue 5, 2012, Pages 784-796

  Giménez Bastida, Juan A ^a,b   González Sarrías, Antonio ^a,b   Larrosa, Mar ^a,b   Tomás Barberán, Francisco ^a,b   Espín, Juan C ^a,b   García Conesa, María Teresa ^a,b  

^a Research Group on Quality   (Spain)

^b RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Angiogenesis; Atherosclerosis; Cell adhesion; Cell migration; Microbiota metabolites

Indexed keywords

3,8 DIHYDROXY 6H DIBENZO(B,D)PYRAN 6 ONE; 3,8 DIHYDROXY 6H DIBENZO(B,D)PYRAN 6 ONE GLUCURONIDE; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE GLUCURONIDE; CCL2 PROTEIN, HUMAN; COUMARIN DERIVATIVE; CYTOKINE; GLUCURONIDE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN; SIGNAL PEPTIDE; TANNIN; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; CELL ADHESION; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; METABOLISM; MONOCYTE; SYNTHESIS;

AORTA; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; COUMARINS; CYTOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCURONIDES; HUMANS; HYDROLYZABLE TANNINS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; MONOCYTES; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861684487     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100677     Document Type: Article

References (41)

1. Villablanca, A. C., Jayachandran, M., Banka, C., Atherosclerosis and sex hormones: current concepts. Clin. Sci. 2010, 119, 493-513.
2. Libby, P., Ridker, P. M., Hansson, G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473, 317-325.
3. Esper, R. J., Nordaby, R. A., Vilariño, J. O., Paragano, A. et al., Endothelial dysfunction: a comprehensive appraisal. Cardiovasc. Diabetol. 2006, 5, 1-18.
4. Becker, B. F., Heindl, B., Kupatt, C., Zahler, S., Endothelial function and hemostasis. Z. Kardiol. 2000, 89, 160-167.
5. Sprague, A. H., Khalil, R. A., Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 2009, 78, 539-552.
6. Bradley, J. R., TNF-mediated inflammatory disease. J. Pathol. 2008, 214, 149-160.
7. Zhang, H., Park, Y., Wu, J., Chen, X. et al., Role of TNF-α in vascular dysfunction. Clin. Sci. 2009, 116, 219-230.
8. Zagorchev, L., Mulligan-Keboe, M. J., Advances in imaging angiogenesis and inflammation in atherosclerosis. Thromb. Haemost. 2011, 105, 820-827.
9. Yoshida, S., Ono, M., Shono, T., Izumi, H. et al., Involvement of Interleukin-8, vascular endothelial growth factor, and basic fibroblasts growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 1997, 17, 4015-4023.
10. Szekanecz, Z., Shah, M. R., Harlow, L. A., Pearce, W. H. et al., Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. Pathobiology 1994, 62, 134-139.
11. Schiffrin, E. L., Antioxidants in hypertension and cardiovascular disease. Mol. Interv. 2010, 10, 354-362.
12. Larrosa, M., García-Conesa, M. T., Espín, J. C., Tomás-Barberán, F. A., Ellagitannins, ellagic acid and vascular health. Mol. Aspects Med. 2010, 31, 513-539.
13. Kaway, Y., Immunochemical detection of food-derived polyphenols in the aorta: macrophages as a major target underlying the anti-atherosclerosis activity of polyphenols. Biosci. Biotechnol. Biochem. 2011, 75, 609-617.
14. Espín, J. C., González-Barrio, R., Cerdá, B., López-Bote, C. et al., Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agric. Food Chem. 2007, 55, 10476-10485.
15. Cerdá, B., Espín, J. C., Parra, S., Martínez, P. et al., The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivates by the colonic microflora of healthy humans. Eur. J. Nutr. 2004, 43, 205-220.
16. González-Sarrías, A., Giménez-Bastida, J. A., García-Conesa, M. T., Gómez-Sánchez, M. B. et al., Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol. Nutr. Food Res. 2010, 54, 311-322.
17. Larrosa, M., González-Sarrías, A., Yánez-Gascón, M. J., Selma, M. V. et al., Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation of phenolic metabolism. J. Nutr. Biochem. 2010, 21, 717-725.
18. González-Sarrías, A., Larrosa, M., Tomás-Barberán, F. A., Dolara, P. et al., NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr. 2010, 104, 503-512.
19. Lucas, R., Alcantara, D., Morales, J. C., A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol. Carbohydr. Res. 2009, 344, 1340-1346.
20. van Meerloo, J., Kaspers, G.J., Cloos, J., Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 2011, 731, 237-45.
21. Eisen, M. B., Brown, P. O., DNA arrays for analysis of gene expression. Methods Enzymol. 1999, 303, 179-205.
22. Fumeaux, R., Menozzi-Smarrito, C., Stalmach, A., Munari, C. et al., First synthesis, characterization, and evidence for the presence of hydroxycinnamic acid sulphate and glucuronide conjugates in human biological fluids as a result of coffee consumption. Org. Biomol. Chem. 2010, 8, 5199-5211.
23. González-Manzano, S., González-Paramás, A., Santos-Buelga, C., Dueñas, M., Preparation and characterization of catechin sulfates, glucuronides, and methylethers with metabolic interest. J. Agric. Food Chem. 2009, 57, 1231-1238.
24. O'Leary, K. A., Day, A. J., Needs, P. W., Sly, W. S. et al., Flavonoid glucuronides are substrates for human liver β-glucuronidase. FEBS Lett. 2001, 503, 103-106.
25. Pfeiffer, E., Hildebrand, A., Mikula, H., Metzler, M., Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms. Mol. Nutr. Food Res. 2010, 54, 1468-1476.
26. González-Barrio, R., Truchado, P., Ito, H., Espín, J. C. et al., UV and MS identification of urolithins and nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals. J. Agric. Food Chem. 2011, 59, 1152-1162.
27. Gössl, M., Herrmann, J., Tang, H., Versari, D. et al., Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res. Cardiol. 2009, 104, 695-706.
28. Li, Y., Flores, R., Yu, A., Okcu, M. F. et al., Elevated expression of CXC chemokines in pediatric osteosarcoma patients. Cancer 2011, 5, 207-217.
29. Wang, C., Peyron, P., Mestre, O., Kaplan, G. et al., Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS One 2010, 5, 1-8.
30. Deshmane, S., Kremlev, S., Amini, S., Sawaya, B. E., Monocyte chemoattractant protein 1 (MPC-1): an overview. J. Interferon Cytokine Res. 2009, 29, 313-326.
31. Barrientos, S., Stojadinovic, O., Golinko, M. S., Brend, H. et al., Growth factors and cytokines in wound healing. Wound Rep. Reg. 2008, 16, 585-601.
32. Imanishi, J., Kamiyama, K, Iguchi, I., Kita, M. et al., Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog. Retin. Eye Res. 2000, 19, 113-129.
33. Takimoto, T., Suzuki, K., Arisaka, H., Murata, T. et al., Effect of N-(p-coumaroyl) serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells. Mol. Nutr. Food Res. 2011, 55, 1-11.
34. Stefansson, S., McMahon, G. A., Petitclerc, E., Lawrence, D. A., Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodelling. Curr. Pharm. Des. 2003, 9, 1545-1564.
35. Kruithof, E. K. O., Regulation of plasminogen activator inhibitor type I gene expression by inflammatory mediators and statins. Thromb. Haemost. 2088, 100, 969-975.
36. Tribolo, S., Lodi, F., Connor, C., Suri, S. et al., Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 2008, 197, 50-56.
37. Ishizawa, K., Yoshizumi, M., Kawai, Y., Terao, J. et al., Pharmacology in health food: Metabolism of quercetin in vivo and its protective effect against arteriosclerosis. J. Pharmacol. Sci. 2011, 115, 466-470.
38. Winterbone, M. S., Tribolo, S., Needs, P. W., Kroon, P. A. et al., Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202, 431-438.
39. Suri, S., Taylor, M. A., Verity, A., Tribolo, S., A comparative study of the effects of quercetin and its glucuronide and sulphate metabolites on human neutrophil function in vitro. Biochem. Pharmacol. 2008, 76, 645-653.
40. Al-Shalmani, S., Suri, S., Hughes, D. A., Kroon, P. A., Quercetin and its principal metabolites, but not myricetin, oppose lipopolysaccharide-induced hyporesponsiveness of the porcine isolated coronary artery. Br. J. Pharmacol. 2011, 162, 1485-1497.
41. Azorín-Ortuño, M., Yañez-Gascón, M. J., Vallejo, F., Pallarés, F. J. et al., Metabolites and tissue distribution of resveratrol in the pig. Mol. Nutr. Food Res. 2011, 55, 1154-1168.